Isoquercitroside Uses, Dosage, Side Effects and more
Isoquercitroside is under investigation in clinical trial NCT04622865 (Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19).
| Attribute | Details |
|---|---|
| Trade Name | Isoquercitroside |
| Generic | Isoquercitrin |
| Isoquercitrin Other Names | Isoquercetin enzymatically modified, Isoquercitroside, Isotrifoliin, Isotrifolin, Quercetin 3-(beta-D-glucofuranoside) |
| Type | |
| Formula | C21H20O12 |
| Weight | Average: 464.379 Monoisotopic: 464.095476084 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
